• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THORATEC CORPORATION HEARTMATE II LVAS IMPLANT KIT (WITH SEALED GRAFTS); VENTRICULAR (ASSISST) BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THORATEC CORPORATION HEARTMATE II LVAS IMPLANT KIT (WITH SEALED GRAFTS); VENTRICULAR (ASSISST) BYPASS Back to Search Results
Model Number 104911
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Aortic Regurgitation (1716); Right Ventricular Dysfunction (2054)
Event Date 06/04/2020
Event Type  Injury  
Manufacturer Narrative
Event date estimated.Date of imaging used.No further information was provided.A supplemental report will be submitted when the manufacturer¿s investigation is completed.
 
Event Description
(b)(6) 2020 echo revealed mild continuous aortic regurgitation.Right ventricular cavity size was mildly dilated with mildly decreased right ventricular systolic function.La moderately dilated.There was mild dilatation of the ascending aorta.
 
Manufacturer Narrative
Manufacturer's investigation conclusion: a direct correlation between (b)(6) and the reported right heart failure and regurgitation could not be conclusively determined through this evaluation.Multiple requests for additional information regarding this event were submitted to the account; no response has been received at this time.The heartmate ii left ventricular assist system (lvas) instructions for use (ifu) lists right heart failure as a possible adverse event associated with the use of hmii therapy.This document also warns that moderate to severe aortic insufficiency must be corrected at time of device implant.The patent remains ongoing on (b)(6).Heartmate ii (hmii) left ventricular assist system (lvas) instructions for use (ifu) is currently available.Section 1 of this document lists right heart failure as a possible adverse event associated with the use of hmii therapy.Section 5 "surgical procedures" warns that moderate to severe aortic insufficiency must be corrected at time of device implant.Section 6 ¿patient care and management¿ describes that right heart failure can occur post-implant and provides strategies for treating patients who experience right heart failure.No further information was provided.The manufacturer is closing the file on this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEARTMATE II LVAS IMPLANT KIT (WITH SEALED GRAFTS)
Type of Device
VENTRICULAR (ASSISST) BYPASS
Manufacturer (Section D)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
MDR Report Key10401313
MDR Text Key202710301
Report Number2916596-2020-03958
Device Sequence Number1
Product Code DSQ
UDI-Device Identifier00813024011170
UDI-Public00813024011170
Combination Product (y/n)N
PMA/PMN Number
P060040
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 09/01/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date10/31/2013
Device Model Number104911
Device Catalogue Number104911
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 07/24/2020
Initial Date FDA Received08/13/2020
Supplement Dates Manufacturer Received08/31/2020
Supplement Dates FDA Received09/01/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age71 YR
Patient Weight97
-
-